Biotech entity
Every one of those 1 sits in a single category, ipo. Of the tracked stories, 1 of 1 also mention Jeffrey Cheah, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Sunway Group, all published on February 28, 2026.
Last mentioned: Mar 18, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, ipo. Of the tracked stories, 1 of 1 also mention Jeffrey Cheah, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Sunway Group, all published on February 28, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 2 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Sunway Group. Shared-story counts are live from our verified record — not editorial picks.
Sunway Healthcare, backed by Malaysian billionaire Jeffrey Cheah’s Sunway Group, is set to raise $736 million through an initial public offering to fund its ambitious hospital expansion plans. The move positions the provider to capitalize on rising demand for private medical services and medical tourism across Southeast Asia.
Sunway Group is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
